|
22 May 2025 |
Dr. Reddy's Labs
|
Consensus Share Price Target
|
1222.20 |
1271.14 |
- |
4.00 |
hold
|
|
|
|
|
12 May 2023
|
Dr. Reddy's Labs
|
KRChoksey
|
1222.20
|
5155.00
|
4466.10
(-72.63%)
|
Target met |
Buy
|
|
|
DRReddy’s saw a sequential drop in revenue to INR 63,152 Mn. Global generics, reported a revenue of INR 54,257 Mn, declined by 8% on a QoQ. However, the company witnessed YoY growth of 23.4%, driven by revenue growth in North America, Europe and India, partially offset by a decline of revenues in the emerging markets.
|
|
11 May 2023
|
Dr. Reddy's Labs
|
SMC online
|
1222.20
|
|
4532.00
(-73.03%)
|
Pre-Bonus/ Split |
Results Update
|
|
|
|
|
11 May 2023
|
Dr. Reddy's Labs
|
BOB Capital Markets Ltd.
|
1222.20
|
4900.00
|
4532.00
(-73.03%)
|
Target met |
Hold
|
|
|
Q4 broadly in line as revenue/EBITDA grew 16%/35% YoY (-7%/-23% QoQ), albeit aided by one-offs
|
|
11 May 2023
|
Dr. Reddy's Labs
|
Prabhudas Lilladhar
|
1222.20
|
4500.00
|
4532.00
(-73.03%)
|
Target met |
Sell
|
|
|
|
|
11 May 2023
|
Dr. Reddy's Labs
|
ICICI Direct
|
1222.20
|
5520.00
|
4532.00
(-73.03%)
|
Target met |
Buy
|
|
|
|
|
11 May 2023
|
Dr. Reddy's Labs
|
Motilal Oswal
|
1222.20
|
4500.00
|
4532.00
(-73.03%)
|
Target met |
Neutral
|
|
|
|
|
11 May 2023
|
Dr. Reddy's Labs
|
Axis Direct
|
1222.20
|
5100.00
|
4532.00
(-73.03%)
|
Target met |
Hold
|
|
|
Company Outlook & Guidance: Q4FY22 results were week. However, we believe DRRD's strategy of in investing various businesses may provide growth in the long term.
|
|
07 Feb 2023
|
Dr. Reddy's Labs
|
Geojit BNP Paribas
|
1222.20
|
5166.00
|
4440.25
(-72.47%)
|
Target met |
Buy
|
|
|
|
|
27 Jan 2023
|
Dr. Reddy's Labs
|
Axis Direct
|
1222.20
|
5100.00
|
4314.00
(-71.67%)
|
Target met |
Buy
|
|
|
We recommend a BUY on the stock.
|
|
27 Jan 2023
|
Dr. Reddy's Labs
|
ICICI Direct
|
1222.20
|
5210.00
|
4314.00
(-71.67%)
|
Target met |
Buy
|
|
|
|